Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership5,902 shares
Latest Disclosed Value $ 1,952,795
Jane Street Group, Llc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 5,902 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $1,686,201 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 311,288 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -98.10% during the quarter. The current value of the position is $1,537,471 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 34,600 of underlying shares valued at $11,448,102 USD and put options representing 23,700 of underlying shares valued at $7,841,619 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,902 -305,386 -98.10 1,953 -98.42 0.0001
2026-02-12 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 311,288 -647,462 -67.53 123,784 -71.69 0.0187
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 958,750 935,894 4,094.74 437,190 5,765.96 0.0665
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 22,856 -75,695 -76.81 7,453 -71.99 0.0015
2025-05-19 2025-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 98,551 -62,086 -38.65 26,611 -29.60 0.0067
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 98,551 -62,086 26,611 0.0055
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 160,637 24,356 17.87 37,799 0.85 0.0082
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 136,281 -3,216 -2.31 37,481 10.57 0.0083
2024-08-15 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 139,497 -24,441 -14.91 33,898 38.36 0.0077
2024-05-16 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 163,938 66,575 68.38 24,501 31.47 0.0051
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 97,363 42,327 76.91 18,636 91.22 0.0049
2023-11-15 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 55,036 18,394 50.20 9,747 40.05 0.0032
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,642 -36,227 -49.72 6,960 -52.33 0.0023
2023-05-16 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 72,869 -46,107 -38.75 14,597 -48.37 0.0060
2023-02-15 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 118,976 -154,013 -56.42 28,275 -48.26 0.0131
2022-11-15 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 272,989 143,137 110.23 54,642 188.52 0.0239
2022-08-16 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 129,852 62,289 92.19 18,939 71.67 0.0080
2022-05-17 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 67,563 -48,394 -41.73 11,032 -43.90 0.0036
2022-02-15 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 115,957 100,355 643.22 19,664 567.71 0.0065
2021-11-16 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,602 -44,299 -73.95 2,945 -71.00 0.0010
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 59,901 42,101 236.52 10,155 304.10 0.0040
2021-05-18 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 17,800 10,918 158.65 2,513 180.78 0.0012
2021-02-17 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,882 -7,469 -52.05 895 -57.16 0.0004
2020-11-17 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,351 -65,446 -82.02 2,089 -82.33 0.0013
2020-08-17 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 79,797 73,111 1,093.49 11,819 1,523.49 0.0089
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,686 6,686 728 0.0007
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -11,992 -100.00 0 -100.00
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,992 212 1.80 965 12.87 0.0016
2019-08-15 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,780 -14,102 -54.49 855 -64.64 0.0015
2019-05-16 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 25,882 11,157 75.77 2,418 125.14 0.0039
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,725 -46,807 -76.07 1,074 -80.06 0.0023
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 61,532 61,532 5,385 0.0106
2018-08-15 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -9,237 -100.00 0 -100.00
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,237 5,987 184.22 1,100 166.34 0.0028
2018-02-15 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,250 -5,417 -62.50 413 -59.43 0.0012
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,667 -143 -1.62 1,018 44.81 0.0033
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,810 8,810 703 0.0025
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -44,616 -100.00 0 -100.00
2017-02-15 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 44,616 44,616 1,670 0.0073
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -14,095 -100.00 0 -100.00
2016-05-17 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,095 4,993 54.86 885 3.27 0.0050
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,102 2,856 45.73 857 70.72 0.0053
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,246 -20,716 -76.83 502 -84.47 0.0031
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 26,962 18,933 235.81 3,232 285.68 0.0209
2015-05-12 2015-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 8,029 8,029 838 0.0065
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -4,601 -100.00 0 -100.00
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,601 -10,828 -70.18 291 -71.91 0.0037
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,429 15,429 1,036 0.0115
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 34,600 -28.81 11,448 -40.76 n/a n/a n/a
2026-02-12 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 48,600 -3.19 19,326 -15.58 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 50,200 92.34 22,891 168.99 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 26,100 -78.52 8,511 -74.06 n/a n/a n/a
2025-05-19 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 121,500 -28.61 32,807 -18.08 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 121,500 32,807 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 170,200 -10.09 40,050 -23.08 n/a n/a n/a
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 189,300 -45.90 52,063 -38.77 n/a n/a n/a
2024-08-15 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 349,900 117.33 85,026 253.37 n/a n/a n/a
2024-05-16 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 161,000 241.83 24,061 166.90 n/a n/a n/a
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 47,100 20.46 9,015 30.20 n/a n/a n/a
2023-11-15 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 39,100 70.00 6,925 58.52 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 23,000 -39.31 4,369 -42.47 n/a n/a n/a
2023-05-16 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 37,900 -45.07 7,592 -53.70 n/a n/a n/a
2023-02-15 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 69,000 -1.00 16,398 17.53 n/a n/a n/a
2022-11-15 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 69,700 -67.31 13,951 -55.13 n/a n/a n/a
2022-08-16 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 213,200 62.62 31,095 45.26 n/a n/a n/a
2022-05-17 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 131,100 229.40 21,407 217.19 n/a n/a n/a
2022-02-15 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 39,800 -73.00 6,749 -75.75 n/a n/a n/a
2021-11-16 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 147,400 15.43 27,831 28.56 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 127,700 65.84 21,648 99.12 n/a n/a n/a
2021-05-18 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 77,000 12.41 10,872 22.12 n/a n/a n/a
2021-02-17 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 68,500 -2.42 8,903 -12.90 n/a n/a n/a
2020-11-17 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 70,200 128.66 10,221 124.79 n/a n/a n/a
2020-08-17 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 30,700 -66.63 4,547 -54.59 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 92,000 76.92 10,014 67.21 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 52,000 5,989 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-16 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,600 -83.01 243 -78.23 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 15,300 -64.99 1,116 -70.82 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 43,700 3,825 n/a n/a n/a
2018-08-15 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 10,000 150.00 1,191 134.45 n/a n/a n/a
2018-02-15 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 4,000 -95.85 508 -95.52 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 96,500 410.58 11,338 652.36 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 18,900 67.26 1,507 160.28 n/a n/a n/a
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 11,300 79.37 579 145.34 n/a n/a n/a
2017-02-15 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 6,300 236 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 8,800 488 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 3,200 3.23 257 -30.91 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 3,100 372 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 23,700 -12.55 7,842 -27.24 n/a n/a n/a
2026-02-12 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 27,100 -30.33 10,776 -39.25 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 38,900 62.08 17,738 126.65 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 24,000 -74.19 7,826 -68.83 n/a n/a n/a
2025-05-19 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 93,000 97.03 25,112 126.10 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 93,000 25,112 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 47,200 -46.67 11,107 -54.37 n/a n/a n/a
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 88,500 -27.76 24,340 -18.23 n/a n/a n/a
2024-08-15 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 122,500 -39.71 29,768 -1.98 n/a n/a n/a
2024-05-16 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 203,200 107.56 30,368 62.06 n/a n/a n/a
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 97,900 -10.59 18,739 -3.37 n/a n/a n/a
2023-11-15 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 109,500 195.95 19,392 175.96 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 37,000 -31.35 7,028 -34.92 n/a n/a n/a
2023-05-16 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 53,900 -18.21 10,797 -31.06 n/a n/a n/a
2023-02-15 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 65,900 -34.30 15,661 -21.99 n/a n/a n/a
2022-11-15 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 100,300 -63.07 20,076 -49.32 n/a n/a n/a
2022-08-16 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 271,600 48.42 39,613 32.56 n/a n/a n/a
2022-05-17 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 183,000 -13.96 29,882 -17.16 n/a n/a n/a
2022-02-15 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 212,700 28.83 36,070 15.71 n/a n/a n/a
2021-11-16 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 165,100 66.94 31,173 85.93 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 98,900 783.04 16,766 960.47 n/a n/a n/a
2021-05-18 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 11,200 -73.27 1,581 -70.97 n/a n/a n/a
2021-02-17 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 41,900 -26.36 5,446 -34.27 n/a n/a n/a
2020-11-17 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 56,900 620.25 8,285 608.12 n/a n/a n/a
2020-08-17 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 7,900 25.40 1,170 70.55 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 6,300 46.51 686 38.59 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,300 495 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 7,400 537 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 10,700 936 n/a n/a n/a
2018-08-15 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,700 179.09 3,656 161.52 n/a n/a n/a
2018-02-15 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 11,000 -80.90 1,398 -79.34 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 57,600 928.57 6,767 1,413.87 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 5,600 447 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 5,000 -74.49 277 -77.48 n/a n/a n/a
2016-05-17 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 19,600 444.44 1,230 262.83 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 3,600 339 n/a n/a n/a
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 14,700 234.09 1,762 283.88 n/a n/a n/a
2015-05-12 2015-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 4,400 459 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.